吉非替尼在伴有EGFR敏感突变Ⅱ~ⅢA期非小细胞肺癌术后辅助治疗的应用

    The Application of Geftinib as Adjuvant Therapy for Stage Ⅱ~ⅢA EGFR-Mutant Non-Small Cell Lung Cancer

    /

    返回文章
    返回